Helsinn/Eisai’s Anti-Nausea Combo Akynzeo Could Boost NK-1 Class
Executive Summary
Helsinn and Eisai’s Akynzeo combines two different targets in one oral tablet for chemotherapy-induced nausea and vomiting – the marketed 5-HT3 antagonist Aloxi (palonosetron) and the new entity netupitant, a member of the underused NK-1 inhibitor class.